PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: stock market

HIGHLIGHTS OF PRESCRIBING INFORMATION ACTEMRA …

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These HIGHLIGHTS do not include all the INFORMATION needed to use ACTEMRA safely and effectively. See full PRESCRIBING INFORMATION for ACTEMRA . ACTEMRA (tocilizumab) injection, for intravenous or subcutaneous use Initial Approval: 2010 WARNING: RISK OF SERIOUS INFECTIONS See full PRESCRIBING INFORMATION for complete boxed warning. Serious infections leading to hospitalization or death including tuberculosis (TB), bacterial, invasive fungal, viral, and other opportunistic infections have occurred in patients receiving ACTEMRA .

162 mg administered subcutaneously every other week, followed by an increase to every week based on clinical response Patients at or above 100 kg weight 162 mg administered subcutaneously every week Giant Cell Arteritis (2.2) Recommended Adult Subcutaneous Dosage: The recommended dose of ACTEMRA for adult patients with GCA is 162 mg

Tags:

  Information, Prescribing, Prescribing information, 162 mg

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION ACTEMRA …

Related search queries